Circadian rhythms and depression: A narrative review of human research.

QUALITY IN

Bidirectional relationship between sleep disturbance and depression: Mechanisms, clinical implications, and future directions

Sleep disturbance is one of the most common and clinically important features of depressive disorders. Although it has traditionally been viewed as a secondary symptom of depression, growing evidence indicates that sleep disturbance plays an active role in both the development and persistence of depressive illness. Longitudinal and experimental studies demonstrate that insomnia, poor sleep quality, and circadian rhythm disruption increase vulnerability to depression, are associated with greater symptom severity, and elevate the risk of relapse. Conversely, depressive disorders disrupt sleep regulation through characteristic changes in sleep architecture, circadian misalignment, and maladaptive sleep related behaviors, creating a self reinforcing cycle between sleep disturbance and mood dysregulation. Shared mechanisms underlying this bidirectional relationship include alterations in monoaminergic neurotransmission, hypothalamic pituitary adrenal axis activation, circadian rhythm disruption, inflammatory processes, and impaired emotional regulation. Clinical evidence further suggests that interventions targeting sleep, particularly cognitive behavioral therapy for insomnia and chronotherapeutic approaches, can reduce depressive symptoms and improve treatment outcomes when integrated into standard depression care. This narrative review synthesizes current evidence on the bidirectional relationship between sleep disturbance and depression and highlights its implications for clinical practice and future research.

Sleep Disturbances and Depression: A Narrative Review of the Bidirectional Relationship, Mechanisms, and the Role of Physical Activity

Introduction and aim: Depression and sleep disturbances are common conditions that frequently co-occur and contribute substantially to the global burden of disease. This review summarizes current evidence on their bidirectional relationship and the role of physical activity as a modifiable therapeutic factor. Material and methods: A narrative review of studies indexed in PubMed, Scopus, and Google Scholar was conducted. Epidemiological, longitudinal, mechanistic, and interventional studies, including systematic reviews and meta-analysis, were analyzed. Results: Insomnia is a consistent predictor of future depression, while depression negatively affects sleep quality, supporting a reciprocal relationship. Shared mechanisms include altered sleep architecture, REM sleep abnormalities, circadian disruption, and emotional dysregulation. This association is observed across different populations, including children, perinatal women and elder people, and is linked to increased suicide risk. Physical activity and exercise improve both sleep quality and depressive symptoms and may help break this cycle. Conclusions: Sleep disturbances and depression are bidirectionally linked. Early identification and treatment of sleep problems, together with promotion of physical activity, may improve outcomes and support depression prevention.

When the biological clock is disordered: circadian rhythm disruption as a core pathophysiological mechanism in anxiety and depression

Anxiety and depressive disorders impose a heavy global burden. Although sleep disturbances have traditionally been regarded as secondary symptoms of these conditions, converging evidence now implicates circadian rhythm disruption as a core pathophysiological mechanism rather than a mere epiphenomenon. This review systematically explores the circadian system and constructs an integrated framework linking disruption to the synergistic dysregulation of multiple pathways and subsequent emotional/sleep abnormalities. We systematically examine five key mechanistic pathways: the SCN-limbic circuit, HPA axis, immune inflammation, neurotransmitter plasticity, and the gut-brain axis. Furthermore, we define actionable subtypes of disruption, summarize chronotherapies (e.g., light therapy, melatonin), and analyze current controversies regarding causality. Finally, we propose future directions, including multi-omics sampling and personalized intervention algorithms. By integrating evidence linking circadian disruption to anxiety/depression, this paper highlights its central mechanistic value, providing theoretical support for precision psychiatry and the integration of circadian medicine.

Circadian rhythm disruption and multiple sclerosis: The role of affective symptoms and temperamental traits.

Systematic assessment of mood and circadian rhythms may offer a more comprehensive framework for identifying clinically relevant chronobiological disruption in patients with multiple sclerosis.

Circadian dimensions in insomnia disorder: mechanistic evidence, candidate phenotypes, and a phenotype-stratified research framework

Insomnia disorder is one of the most common sleep disorders and is traditionally conceptualized in terms of hyperarousal, altered sleep homeostasis, and cognitive-behavioral perpetuating factors. The two-process model of sleep regulation indicates that sleep initiation and maintenance depend not only on homeostatic sleep pressure but also on circadian phase, amplitude, and stability. Evidence suggests that some patients presenting with insomnia complaints have misalignment between endogenous circadian phase and the intended sleep window, whereas others show reduced rest-activity amplitude, increased sleep-timing variability, or abnormal light exposure patterns. This narrative review integrates clinical, measurement, mechanistic, and intervention evidence on circadian dimensions in insomnia disorder and proposes a candidate circadian phenotyping framework for future validation. The framework combines sleep diaries, actigraphy, light exposure assessment, dim-light melatonin onset (DLMO), and core body temperature rhythms to distinguish circadian rhythm sleep-wake disorder (CRSWD)-dominant insomnia complaints, insomnia disorder with circadian modifiers, and comorbid insomnia disorder and CRSWD. Cognitive behavioral therapy for insomnia (CBT-I) remains first-line treatment. Fixed wake time, morning light, evening light restriction, timed low-dose melatonin, scheduled activity, and multicomponent approaches are positioned as candidate adjunctive modules to be tested in phenotype-stratified trials. These phenotypes are not diagnostic categories, clinical decision algorithms, or treatment guidelines. The review instead translates circadian evidence in insomnia into testable propositions, including provisional phenotype definitions, recommended measurement strategies, falsifiable predictions, and future trial designs. Operational thresholds, reproducibility, predictive validity, incremental treatment benefit, optimal parameters, safety, implementation feasibility, and cost-effectiveness require prospective phenotype-stratified randomized trials and long-term follow-up.